Clinical trial · Interventional
Melanoma Risk Assessment & Tailored Intervention
Melanoma Risk Assessment and Skin Cancer Awareness, Prevention, and Education in a Primary Care Setting
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators are conducting a study to provide evidence about the comparative effectiveness of mailed, tailored intervention materials on cancer prevention behavioral outcomes. The investigators will send out three (3) tailored mailings for participants who are assigned to the intervention group. Second, during the eligibility screening, the investigators will be assessing the relative yield and functioning of two risk assessment tools (BRAT and FEARS) on determining an individual's level of risk for skin cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surveys & Mailed Materials | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Control Group
- interventionNames
- Other: Surveys & Mailed Materials
- type
- OTHER
- label
- Tailored Intervention
- description
- We will mail three separate pamphlets created specifically for the participant. The information in the pamphlets will be based on answers from the first survey.
- interventionNames
- Other: Surveys & Mailed Materials
Primary outcomes (1)
- measure
- Compare the effects of offering tailored print materials to that of generic print materials on perceived risk of melanoma, sun avoidance/protection, and skin self-examination behaviors.
- timeFrame
- 3-6 months total per participant
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: To be included in Phase I, a subject must meet all of the following criteria: 1. Subjects are capable of giving informed consent 2. Subjects are ≥ 18 years old. 3. Subjects are English speaking and can read English To be included for analysis during Phase II, a subject must meet all of the following criteria: 1. Subjects must meet all criteria listed in Phase I. 2. Subjects are identified as Caucasian. 3. Subjects must be at moderate or high risk for skin cancer, based on scores from the BRAT and Fears combined risk assessment. Exclusion Criteria: 1. Children under the age of 18 will not be included. 2. For Phase II, previously diagnosed with melanoma. 3. For Phase II, planning to be away for three (3) consecutive weeks or longer in June, July, or August
References
Publications (0)
Data not yet available